NASDAQ · IVF

INVO Fertility, Inc.

Closing price · Nov 13, 2026 $2.60

Latest quarter · ended Jun 30, 2026

Cash got weaker, but sales grew

descriptionFiled Aug 14, 2026
Revenue growthSlower
+16.7%
Quarter ended Sep 30, 2024: +47.0% sales vs. a year beforeQuarter ended Dec 31, 2024: +22.0% sales vs. a year beforeQuarter ended Mar 31, 2025: +3.9% sales vs. a year beforeQuarter ended Jun 30, 2025: +1.5% sales vs. a year beforeQuarter ended Sep 30, 2025: +22.6% sales vs. a year beforeQuarter ended Dec 31, 2025: −6.1% sales vs. a year beforeQuarter ended Mar 31, 2026: +23.1% sales vs. a year beforeQuarter ended Jun 30, 2026: +16.7% sales vs. a year before
Sep '24Jun '26
$2.18M vs. $1.86M a year ago
Cash from operationsBetter
−$1.1M
Quarter ended Sep 30, 2024: −$641K cash from operationsQuarter ended Dec 31, 2024: −$617K cash from operationsQuarter ended Mar 31, 2025: −$3.55M cash from operationsQuarter ended Jun 30, 2025: −$1.72M cash from operationsQuarter ended Sep 30, 2025: −$1.78M cash from operationsQuarter ended Dec 31, 2025: $25.2K cash from operationsQuarter ended Mar 31, 2026: −$1.92M cash from operationsQuarter ended Jun 30, 2026: −$1.1M cash from operations
Sep '24Jun '26
vs. −$1.72M a year ago
Share countBuying back
−42.5%
Quarter ended Sep 30, 2024: 4.94M sharesQuarter ended Dec 31, 2024: 1.07M sharesQuarter ended Mar 31, 2025: 1.07M sharesQuarter ended Jun 30, 2025: 4.36M sharesQuarter ended Sep 30, 2025: 15.13M sharesQuarter ended Dec 31, 2025: 1.79M sharesQuarter ended Mar 31, 2026: 1.79M sharesQuarter ended Jun 30, 2026: 2.51M shares
Sep '24Jun '26
2.51M shares vs. 4.36M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    1 real insider sale in 12 months. $6 in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

10 funds report owning IVF, up from 8

Holdings as of Jun 30, 2026
New8
Added1
Held1
Trimmed0
Sold out6

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovCode J · Dec 4 · 3 shOpen-market sale · Dec 3 · $6
CEOCFOOther officersDirectorsDecFebAprJunAugOctCode J · Dec 4 · 3 shOpen-market sale · Dec 3 · $6

Last 12 months. No real trades in the last 6.

Showing 1 real trade. Bigger dot means a bigger trade.

Real trades, newest first

Dec 3 Matthew Szot Director Open-market sale $6 4 sh at $1.52 Sold 57% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in IVF

As of Jun 30, 2026
FundOwnsValueChange
Virtu Financial LLC2.5%$120KNew
Scientech Research LLC1.3%$61.4KNew
StoneX Group Inc.0.6%$29.8KNew
Susquehanna International Group, LLP0.5%$21.8KNew
Tower Research Capital LLC (trc)0.3%$15.5KNew

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast